TGF-β1 gene polymorphism in renal transplant patients with and without gingival overgrowth

Oral Diseases

Volumn 17, Issue 4, 2011, Pages 414-419

  Kozak, M ^a   Kurzawski, M ^a   Wajda, A ^a   Lapczuk, J ^a   Lipski, M ^b   Dziewanowski, K ^c   Drozdzik, M ^a  

^a Departments of Pharmacology   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Department of General and Transplantation Surgery   (Poland)

Author keywords

Gingival overgrowth; Polymorphism; TGF 1

Indexed keywords

CYCLOSPORIN A; DILTIAZEM; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA1; VERAPAMIL;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GINGIVA OVERGROWTH; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENINE; ADOLESCENT; ADULT; AGED; ARGININE; CASE-CONTROL STUDIES; CODON; CYCLOSPORINE; CYTOSINE; FEMALE; GENE FREQUENCY; GENOTYPE; GINGIVAL OVERGROWTH; GUANINE; HAPLOTYPES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUCINE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLINE; PROMOTER REGIONS, GENETIC; THYMINE; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 79953760133     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01769.x     Document Type: Article

References (27)

1. Afonso M, de Oliveira Bello V, Shibli JA, Sposto MR (2003). Cyclosporine A-induced gingival overgrowth in renal transplant recipients. J Periodontol 74: 51-56.
2. Anderson TJ, Lapp CA, Billman MA, Schuster GS (1998). Effects of transforming growth factor-beta and platelet derived growth factor on human gingival fibroblasts grown in serum-containing and serum-free medium. J Clin Periodontol 25: 48-55.
3. Buduneli N, Kutukculer N, Aksa G, Atilla G (2001). Evaluation of transforming growth factor-beta1 level in crevicular fluid of cyclosporin A-treated patients. J Periodontol 72: 526-531.
4. Cotrim P, de Andrade CR, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD (2002). Expression of matrix metalloproteinases in cyclosporine-related gingival fibroblasts is regulated by transforming growth factor (TGF)-β1 autocrine stimulation. J Periodontol 73: 1313-1322.
5. Dreyfuss JL, Veiga SS, Coulson-Thomas VJ et al (2010). Differences in the expression of glycosaminoglycans in human fibroblasts derived from gingival overgrowths is related to TGF-beta up-regulation. Growth Factors 28: 24-33.
6. Edwards DR, Murphy G., Reynolds JJ et al (1987). Transforming growth factor beta modulates the expression of collagenase nad metalloproteinase inhibitor. EMBO J 6: 1899-1904.
7. Ellis JS, Morgan CI, Kirby JA, Taylor JJ, Thomason JM (2004). Plasma TGF-β1 as a risk factor for gingival overgrowth. J Clin Periodontol 31: 863-868.
8. Grainger DJ, Mosedale DE, Metcalfe JC (2000). TGF-β in blood: a complex problem. Cytokine Growth Factor Rev 11: 133-145.
9. Grigner DJ, Heathcote K, Chiano M et al (1999). Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8: 93-97.
10. Gurkan A, Afacan B, Emingil G, Toz H, Baskesen A, Atilla G (2008). Gingival crevicular fluid transforming growth factor-β1 in cyclospotine and tacrolimus treated renal transplant patients without gingival overgrowth. Arch Oral Biol 53: 723-728.
11. James JA, Invin CR, Linden GJ (1998). Gingival fibroblast response to cyclosporine A and transforming factor beta 1. J Periodontal Res 33: 40-48.
12. Linden GJ, Haworth SE, Maxwell P et al (2001). The influence of transforming growth factor- β1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporine A and a calsium channel blocker. J Periodontol 72: 808-814.
13. Margiotta V, Pizzo I, Pizzo G, Barbaro A (1996). Cyclosporine- and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 25: 128-134.
14. McGaw WT, Porter H (1988). Cyclosporin-induced gingival overgrowth: an ultrastructural stereologic study. Oral Surg 65: 186-190.
15. Overall CM, Warana JL, Sodek J (1989). Independent regulation of collagenaze 72-kDa progelatinase and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor β. J Biol Chem 264: 1860-1869.
16. Pernu HE, Pernu HM, Huttunen KR, Nieminen PA, Knuuttila ML (1992). Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 63: 548-553.
17. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML (2001). Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 62: 548-553.
18. Pulleyn LJ, Newton R, Adcock IM, Barnes PJ (2001). TGFbeta1 allele association with asthma severity. Hum Genet 2001: 109.
19. Radwan-Oczko M, Boratynska M, Zietek M, Zoledziewska M, Jonkisz A (2006). The relationship of transforming growth factor- β1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. J Periodontol 77: 865-873.
20. Radwan-Oczko M, Boratynska M, Zietek M, Dobosz T (2008). Transforming growth factor-β1 gene expression and cyclosporine A-induced gingival overgrowth: a pilot study. J Clin Periodontol 35: 371-378.
21. Seymour RA, Thomason JM, Ellis JS (1996). The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 23: 165-175.
22. Somacarrera ML, Hernandez G, Acero J, Moskow BS (1994). Factors relating to the incidence and severity of cyclosporine-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontal Res 65: 671-675.
23. Thomas DW, Newcombe RG, Osborne G (2000). Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 70: 552-556.
24. Thomas DW, Baboolal K, Subtamanian N, Newcombe RG (2001). Cyclosporine A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol 28: 706-709.
25. Thomasson JM, Ellis JS, Kelly PJ, Seymour RA (1997). Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients. Clin Oral Invest 1: 35-39.
26. Wilson RF, Morel A, Smith D et al (1998). Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. J Clin Periodontol 25: 457-464.
27. Yoshida T, Nagata J, Yamane A (2005). Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A. J Periodontal Res 40: 11-19.